Learn More
ANCELL CORPORATION Human CD152 CTLA-4 Fusion Protein, Immune Checkpoint Regulator, High-Affinity Binding, 25 µg
Supplier: ANCELL CORPORATION 501820
The ANCELL CORPORATION Human CD152 CTLA-4 (25 µg) is a potent negative regulator of T cell activation, designed as a soluble dimeric fusion protein. It exhibits high-affinity binding to CD80 and CD86, making it an essential tool for researchers studying immune checkpoint interactions. This product aids in investigating T cell signaling pathways and immune regulation, distinguishing it from other offerings with its optimized format for various in vitro assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.